1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 20
2 Introduction 21
2.1 Inborn Gene or Chromosome Alterations Overview 21
3 Products under Development 22
3.1 Inborn Gene or Chromosome Alterations – Pipeline Products by Stage of Development 22
3.2 Inborn Gene or Chromosome Alterations – Pipeline Products by Territory 23
3.3 Inborn Gene or Chromosome Alterations – Pipeline Products by Regulatory Path 24
3.4 Inborn Gene or Chromosome Alterations – Pipeline Products by Estimated Approval Date 25
3.5 Inborn Gene or Chromosome Alterations – Ongoing Clinical Trials 26
4 Inborn Gene or Chromosome Alterations – Pipeline Products under Development by Companies 27
4.1 Inborn Gene or Chromosome Alterations Companies – Pipeline Products by Stage of Development 27
4.2 Inborn Gene or Chromosome Alterations – Pipeline Products by Stage of Development 31
5 Inborn Gene or Chromosome Alterations Companies and Product Overview 38
5.1 Aarhus University Company Overview 38
5.1.1 Aarhus University Pipeline Products & Ongoing Clinical Trials Overview 38
5.2 AbaStar MDx Inc Company Overview 39
5.2.1 AbaStar MDx Inc Pipeline Products & Ongoing Clinical Trials Overview 39
5.3 AC-Gen Reading Life S.L. Company Overview 42
5.3.1 AC-Gen Reading Life S.L. Pipeline Products & Ongoing Clinical Trials Overview 42
5.4 Agena Bioscience Inc Company Overview 43
5.4.1 Agena Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 43
5.5 Alexion Pharmaceuticals Inc Company Overview 44
5.5.1 Alexion Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 44
5.6 Allele Diagnostics Inc Company Overview 45
5.6.1 Allele Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 45
5.7 Amarantus Bioscience Holdings Inc Company Overview 46
5.7.1 Amarantus Bioscience Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 46
5.8 Amity University Company Overview 47
5.8.1 Amity University Pipeline Products & Ongoing Clinical Trials Overview 47
5.9 Arrayit Corporation Company Overview 48
5.9.1 Arrayit Corporation Pipeline Products & Ongoing Clinical Trials Overview 48
5.10 Asuragen Inc Company Overview 49
5.10.1 Asuragen Inc Pipeline Products & Ongoing Clinical Trials Overview 49
5.11 Augusta University Company Overview 50
5.11.1 Augusta University Pipeline Products & Ongoing Clinical Trials Overview 50
5.12 AutoGenomics Inc Company Overview 51
5.12.1 AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview 51
5.13 Baylor College of Medicine Company Overview 54
5.13.1 Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 54
5.14 BioCeps (Inactive) Company Overview 55
5.14.1 BioCeps (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 55
5.15 Biocept Inc Company Overview 56
5.15.1 Biocept Inc Pipeline Products & Ongoing Clinical Trials Overview 56
5.16 Biofidelity Ltd Company Overview 57
5.16.1 Biofidelity Ltd Pipeline Products & Ongoing Clinical Trials Overview 57
5.17 Boston Children’s Hospital Company Overview 58
5.17.1 Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 58
5.18 Cardiff Oncology Inc Company Overview 60
5.18.1 Cardiff Oncology Inc Pipeline Products & Ongoing Clinical Trials Overview 60
5.19 CareDx Inc Company Overview 61
5.19.1 CareDx Inc Pipeline Products & Ongoing Clinical Trials Overview 61
5.20 Celula Inc Company Overview 65
5.20.1 Celula Inc Pipeline Products & Ongoing Clinical Trials Overview 65
5.21 Children’s Hospital of Philadelphia Company Overview 66
5.21.1 Children’s Hospital of Philadelphia Pipeline Products & Ongoing Clinical Trials Overview 66
5.22 China Medical Technologies Inc (Inactive) Company Overview 67
5.22.1 China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 67
5.23 ChipCare Corp Company Overview 68
5.23.1 ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview 68
5.24 ChromaCode Inc Company Overview 69
5.24.1 ChromaCode Inc Pipeline Products & Ongoing Clinical Trials Overview 69
5.25 Chronix Biomedical Inc Company Overview 70
5.25.1 Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 70
5.26 Cincinnati Children’s Hospital Medical Center Company Overview 71
5.26.1 Cincinnati Children’s Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview 71
5.27 Columbia University Company Overview 75
5.27.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 75
5.28 Consejo Superior de Investigaciones Cientificas Company Overview 77
5.28.1 Consejo Superior de Investigaciones Cientificas Pipeline Products & Ongoing Clinical Trials Overview 77
5.29 Daan Gene Co Ltd Company Overview 78
5.29.1 Daan Gene Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 78
5.30 Decipher GenX, Inc. Company Overview 79
5.30.1 Decipher GenX, Inc. Pipeline Products & Ongoing Clinical Trials Overview 79
5.31 Duke University Company Overview 80
5.31.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 80
5.32 Echelon Diagnostics Inc Company Overview 81
5.32.1 Echelon Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 81
5.33 EGIS Pharmaceuticals Plc Company Overview 82
5.33.1 EGIS Pharmaceuticals Plc Pipeline Products & Ongoing Clinical Trials Overview 82
5.34 Eone Diagnomics Genome Center Co Ltd Company Overview 83
5.34.1 Eone Diagnomics Genome Center Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 83
5.35 Epinex Diagnostics Inc Company Overview 87
5.35.1 Epinex Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 87
5.36 Fina Biotech SL Company Overview 88
5.36.1 Fina Biotech SL Pipeline Products & Ongoing Clinical Trials Overview 88
5.37 Firalis SAS Company Overview 89
5.37.1 Firalis SAS Pipeline Products & Ongoing Clinical Trials Overview 89
5.38 Fluidigm Corp Company Overview 90
5.38.1 Fluidigm Corp Pipeline Products & Ongoing Clinical Trials Overview 90
5.39 Fraunhofer Institute for Cell Therapy and Immunology Company Overview 91
5.39.1 Fraunhofer Institute for Cell Therapy and Immunology Pipeline Products & Ongoing Clinical Trials Overview 91
5.40 Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung eV Company Overview 92
5.40.1 Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung eV Pipeline Products & Ongoing Clinical Trials Overview 92
5.41 Fred Hutchinson Cancer Research Center Company Overview 93
5.41.1 Fred Hutchinson Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview 93
5.42 French National Institute of Health and Medical Research Company Overview 95
5.42.1 French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview 95
5.43 genedrive plc Company Overview 98
5.43.1 genedrive plc Pipeline Products & Ongoing Clinical Trials Overview 98
5.44 Genentech USA Inc Company Overview 101
5.44.1 Genentech USA Inc Pipeline Products & Ongoing Clinical Trials Overview 101
5.45 Genisphere LLC Company Overview 102
5.45.1 Genisphere LLC Pipeline Products & Ongoing Clinical Trials Overview 102
5.46 Genomic Vision SA Company Overview 103
5.46.1 Genomic Vision SA Pipeline Products & Ongoing Clinical Trials Overview 103
5.47 genomiQa Pty Ltd Company Overview 104
5.47.1 genomiQa Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 104
5.48 German Cancer Research Center Company Overview 108
5.48.1 German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview 108
5.49 German Institute of Human Nutrition Company Overview 111
5.49.1 German Institute of Human Nutrition Pipeline Products & Ongoing Clinical Trials Overview 111
5.50 Gilupi GmbH Company Overview 112
5.50.1 Gilupi GmbH Pipeline Products & Ongoing Clinical Trials Overview 112
5.51 GnuBIO Inc Company Overview 113
5.51.1 GnuBIO Inc Pipeline Products & Ongoing Clinical Trials Overview 113
5.52 Hadassah Medical Center Company Overview 114
5.52.1 Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 114
5.53 Hebrew University of Jerusalem Company Overview 115
5.53.1 Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview 115
5.54 Helicos BioSciences Corporation Company Overview 116
5.54.1 Helicos BioSciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 116
5.55 Helmholtz Zentrum Munchen Deutsches Forschungszentrum fur Gesundheit und Umwelt (GmbH) Company Overview 117
5.55.1 Helmholtz Zentrum Munchen Deutsches Forschungszentrum fur Gesundheit und Umwelt (GmbH) Pipeline Products & Ongoing Clinical Trials Overview 117
5.56 Hummingbird Diagnostics GmbH Company Overview 119
5.56.1 Hummingbird Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 119
5.57 iGene Laboratory Pte Ltd Company Overview 120
5.57.1 iGene Laboratory Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 120
5.58 Illumina Inc Company Overview 121
5.58.1 Illumina Inc Pipeline Products & Ongoing Clinical Trials Overview 121
5.59 Indiana University Company Overview 123
5.59.1 Indiana University Pipeline Products & Ongoing Clinical Trials Overview 123
5.60 Interpace Biosciences Inc Company Overview 124
5.60.1 Interpace Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 124
5.61 iXlayer Inc Company Overview 129
5.61.1 iXlayer Inc Pipeline Products & Ongoing Clinical Trials Overview 129
5.62 Johns Hopkins University Company Overview 130
5.62.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 130
5.63 JS Genetics Inc Company Overview 133
5.63.1 JS Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview 133
5.64 Juneau Biosciences LLC Company Overview 134
5.64.1 Juneau Biosciences LLC Pipeline Products & Ongoing Clinical Trials Overview 134
5.65 KellBenx Inc (Inactive) Company Overview 135
5.65.1 KellBenx Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 135
5.66 Laboratory Corp of America Holdings Company Overview 136
5.66.1 Laboratory Corp of America Holdings Pipeline Products & Ongoing Clinical Trials Overview 136
5.67 Laval University Company Overview 137
5.67.1 Laval University Pipeline Products & Ongoing Clinical Trials Overview 137
5.68 LifeCodexx AG Company Overview 140
5.68.1 LifeCodexx AG Pipeline Products & Ongoing Clinical Trials Overview 140
5.69 LineaGen Inc Company Overview 141
5.69.1 LineaGen Inc Pipeline Products & Ongoing Clinical Trials Overview 141
5.70 Lucid Diagnostics Inc Company Overview 142
5.70.1 Lucid Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 142
5.71 Maastricht University Medical Center Company Overview 146
5.71.1 Maastricht University Medical Center Pipeline Products & Ongoing Clinical Trials Overview 146
5.72 Massachusetts Eye and Ear Infirmary Company Overview 147
5.72.1 Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview 147
5.73 Max Delbruck Center for Molecular Medicine Company Overview 149
5.73.1 Max Delbruck Center for Molecular Medicine Pipeline Products & Ongoing Clinical Trials Overview 149
5.74 McGill University Company Overview 150
5.74.1 McGill University Pipeline Products & Ongoing Clinical Trials Overview 150
5.75 Medical Research Council Company Overview 151
5.75.1 Medical Research Council Pipeline Products & Ongoing Clinical Trials Overview 151
5.76 MeMed Diagnostics LTD Company Overview 152
5.76.1 MeMed Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview 152
5.77 Myriad Genetics Inc Company Overview 153
5.77.1 Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview 153
5.78 Nanosphere Inc Company Overview 154
5.78.1 Nanosphere Inc Pipeline Products & Ongoing Clinical Trials Overview 154
5.79 National Jewish Health Company Overview 156
5.79.1 National Jewish Health Pipeline Products & Ongoing Clinical Trials Overview 156
5.80 National University of Singapore Company Overview 157
5.80.1 National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 157
5.81 Nel ASA Company Overview 159
5.81.1 Nel ASA Pipeline Products & Ongoing Clinical Trials Overview 159
5.82 NewGene Ltd Company Overview 160
5.82.1 NewGene Ltd Pipeline Products & Ongoing Clinical Trials Overview 160
5.83 NIPD Genetics Company Overview 163
5.83.1 NIPD Genetics Pipeline Products & Ongoing Clinical Trials Overview 163
5.84 Oxford Biodynamics Plc Company Overview 164
5.84.1 Oxford Biodynamics Plc Pipeline Products & Ongoing Clinical Trials Overview 164
5.85 Oxford Gene Technology Ltd Company Overview 182
5.85.1 Oxford Gene Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 182
5.86 ParagonDx LLC (Inactive) Company Overview 183
5.86.1 ParagonDx LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 183
5.87 PerkinElmer Inc Company Overview 184
5.87.1 PerkinElmer Inc Pipeline Products & Ongoing Clinical Trials Overview 184
5.88 Population Bio Inc Company Overview 185
5.88.1 Population Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 185
5.89 Precipio Inc Company Overview 195
5.89.1 Precipio Inc Pipeline Products & Ongoing Clinical Trials Overview 195
5.90 PreCyte, Inc. Company Overview 196
5.90.1 PreCyte, Inc. Pipeline Products & Ongoing Clinical Trials Overview 196
5.91 PredictImmune Ltd Company Overview 197
5.91.1 PredictImmune Ltd Pipeline Products & Ongoing Clinical Trials Overview 197
5.92 Predictive Therapeutics LLC Company Overview 200
5.92.1 Predictive Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 200
5.93 Predigen Inc Company Overview 203
5.93.1 Predigen Inc Pipeline Products & Ongoing Clinical Trials Overview 203
5.94 Progenity Inc Company Overview 204
5.94.1 Progenity Inc Pipeline Products & Ongoing Clinical Trials Overview 204
5.95 Proove BioScience Inc Company Overview 205
5.95.1 Proove BioScience Inc Pipeline Products & Ongoing Clinical Trials Overview 205
5.96 Quest Diagnostics Inc Company Overview 208
5.96.1 Quest Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 208
5.97 Roche Diagnostics International Ltd Company Overview 209
5.97.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 209
5.98 Sapien Biosciences Company Overview 210
5.98.1 Sapien Biosciences Pipeline Products & Ongoing Clinical Trials Overview 210
5.99 Scipher Medicine Corp Company Overview 212
5.99.1 Scipher Medicine Corp Pipeline Products & Ongoing Clinical Trials Overview 212
5.100 Seattle Children’s Hospital Company Overview 216
5.100.1 Seattle Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 216
5.101 Seegene Inc Company Overview 220
5.101.1 Seegene Inc Pipeline Products & Ongoing Clinical Trials Overview 220
5.102 Sequenom Inc Company Overview 221
5.102.1 Sequenom Inc Pipeline Products & Ongoing Clinical Trials Overview 221
5.103 Sheba Medical Center Company Overview 223
5.103.1 Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview 223
5.104 SkylineDx BV Company Overview 224
5.104.1 SkylineDx BV Pipeline Products & Ongoing Clinical Trials Overview 224
5.105 Sophia Genetics SA Company Overview 225
5.105.1 Sophia Genetics SA Pipeline Products & Ongoing Clinical Trials Overview 225
5.106 StellarGene Technologies Pvt Ltd Company Overview 226
5.106.1 StellarGene Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 226
5.107 Strand Life Sciences Pvt Ltd Company Overview 227
5.107.1 Strand Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 227
5.108 SUNY Upstate Medical University Company Overview 229
5.108.1 SUNY Upstate Medical University Pipeline Products & Ongoing Clinical Trials Overview 229
5.109 Takeda Pharmaceuticals International AG Company Overview 230
5.109.1 Takeda Pharmaceuticals International AG Pipeline Products & Ongoing Clinical Trials Overview 230
5.110 TAmiRNA GmbH Company Overview 231
5.110.1 TAmiRNA GmbH Pipeline Products & Ongoing Clinical Trials Overview 231
5.111 TBG Diagnostics Ltd Company Overview 232
5.111.1 TBG Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 232
5.112 Tel Aviv University Company Overview 233
5.112.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 233
5.113 The Francis Crick Institute Ltd Company Overview 235
5.113.1 The Francis Crick Institute Ltd Pipeline Products & Ongoing Clinical Trials Overview 235
5.114 thromboDx Company Overview 236
5.114.1 thromboDx Pipeline Products & Ongoing Clinical Trials Overview 236
5.115 Transplant Genomics Inc Company Overview 237
5.115.1 Transplant Genomics Inc Pipeline Products & Ongoing Clinical Trials Overview 237
5.116 Tufts Medical Center Company Overview 239
5.116.1 Tufts Medical Center Pipeline Products & Ongoing Clinical Trials Overview 239
5.117 University Hospital of Cologne Company Overview 240
5.117.1 University Hospital of Cologne Pipeline Products & Ongoing Clinical Trials Overview 240
5.118 University of Arizona Company Overview 243
5.118.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 243
5.119 University of California San Diego Company Overview 244
5.119.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 244
5.120 University of California San Francisco Company Overview 245
5.120.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 245
5.121 University of Cambridge Company Overview 246
5.121.1 University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview 246
5.122 University of Cape Town Company Overview 247
5.122.1 University of Cape Town Pipeline Products & Ongoing Clinical Trials Overview 247
5.123 University of Central Florida Company Overview 248
5.123.1 University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview 248
5.124 University of Colorado Company Overview 250
5.124.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 250
5.125 University of Illinois at Chicago Company Overview 251
5.125.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 251
5.126 University of Melbourne Company Overview 252
5.126.1 University of Melbourne Pipeline Products & Ongoing Clinical Trials Overview 252
5.127 University of Michigan Company Overview 253
5.127.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 253
5.128 University of Oxford Company Overview 255
5.128.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 255
5.129 University of Pennsylvania Company Overview 256
5.129.1 University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview 256
5.130 University of Pittsburgh Company Overview 257
5.130.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 257
5.131 University of Turku Company Overview 258
5.131.1 University of Turku Pipeline Products & Ongoing Clinical Trials Overview 258
5.132 Vanadis Diagnostics AB Company Overview 259
5.132.1 Vanadis Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview 259
5.133 Vanderbilt University Company Overview 262
5.133.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 262
5.134 Vanessa Research Inc Company Overview 263
5.134.1 Vanessa Research Inc Pipeline Products & Ongoing Clinical Trials Overview 263
5.135 Virginia Commonwealth University Company Overview 264
5.135.1 Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview 264
5.136 VitaPath Genetics, Inc. Company Overview 265
5.136.1 VitaPath Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 265
5.137 Yale University Company Overview 266
5.137.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview 266
6 Inborn Gene or Chromosome Alterations- Recent Developments 267
6.1 Oct 23, 2020: Yourgene Health: CQC accreditation 267
6.2 Aug 06, 2020: OPKO Health’s GeneDx adds GenomeXpress to its industry-leading clinical genomics portfolio 267
6.3 Jul 31, 2020: Fluidigm selected for $37 million project under National Institutes of Health RADx initiative 268
6.4 Jul 23, 2020: PolyA-miner accurately assesses the effect of alternative polyadenylation on gene expression 269
6.5 Jul 13, 2020: Thermo Fisher Scientific and first genetics JCS partner to develop next-generation sequencing-based diagnostics in Russia 270
6.6 Jul 08, 2020: GenMark Diagnostics: Entry into a Material Definitive Agreement 271
6.7 May 28, 2020: QIAGEN builds on leading position in Precision Medicine with novel solutions in oncology 271
6.8 May 18, 2020: QIAGEN announces publication of Reasoned Position Statement for proposed acquisition by Thermo Fisher and date for Annual General Meeting 272
6.9 May 04, 2020: StageZero Life Sciences announces enhanced relationship with Phleb-Finders 273
6.10 Feb 29, 2020: MGI’s response to Illumina’s complaint 273
6.11 Feb 26, 2020: Thermo Fisher Scientific President and Chief Executive Officer Marc N. Casper elected Chairman of the Board of Directors 273
6.12 Feb 26, 2020: Natera reports fourth quarter and year 2019 financial results 274
6.13 Feb 20, 2020: Oxford BioDynamics to present at BioTech Pharma Summit: Liquid Biopsy 2020 in Lisbon, Portugal 276
6.14 Feb 20, 2020: SOPHiA GENETICS Board of Directors elects Troy Cox as new Chairman 277
6.15 Feb 19, 2020: Invitae reports $216.8 million in annual revenue driven by more than 482,000 samples in 2019 277
6.16 Feb 18, 2020: Hologic Expands Costa Rican operations with new financial shared services center 279
6.17 Feb 13, 2020: LabCorp announces 2019 fourth quarter and full year results and provides 2020 guidance 280
6.18 Feb 12, 2020: Pivotal to provide services to lucid diagnostics´ clinical studies for its GI in-vitro diagnostics Esoguard and Esocheck to facilitate diagnosis of Barrett’s esophagus 283
6.19 Feb 11, 2020: U.S. FDA grants PAVmed Subsidiary, Lucid Diagnostics, Breakthrough Device Designation for its EsoGuard Esophageal DNA Test 284
6.20 Feb 11, 2020: Predictive Technology Group announces beta test results for its ARTguide test 285
6.21 Feb 10, 2020: Luminex reports fourth quarter and full-year 2019 results 286
6.22 Feb 06, 2020: Dr. Scott Gottlieb, former US FDA Commissioner, joins Illumina’s Board of Directors 287
6.23 Feb 06, 2020: Myriad announces leadership transition 288
6.24 Feb 06, 2020: Myriad Genetics reports fiscal second-quarter 2020 financial results 288
6.25 Feb 06, 2020: Dr. Scott Gottlieb, former US FDA Commissioner, joins Illumina’s Board of Directors 290
6.26 Feb 05, 2020: Hologic launches new scalable options for panther system in the United States and Europe 291
6.27 Jan 30, 2020: Quest Diagnostics reports record fourth quarter and full year 2019 revenues and earnings; provides guidance for full year 2020; increases dividend
5.7% to $0.56 per quarter 292
6.28 Jan 30, 2020: Thermo Fisher Scientific reports fourth quarter and full year 2019 results 292
6.29 Jan 27, 2020: Natera files suit against ArcherDX for Patent Infringement 295
6.30 Jan 21, 2020: PredictImmune announces commercial partnership with Cambridge Clinical Laboratories (CCL) to promote and supply PredictSURE IBD, the world’s first validated prognostic test for Inflammatory Bowel Disease 295
6.31 Jan 14, 2020: Fluidigm provides preliminary financial results for fourth quarter and fiscal year 2019 296
6.32 Jan 14, 2020: Dr. Thomas P. Slavin named Senior Vice President of Medical Affairs for Myriad Oncology 296
6.33 Jan 13, 2020: GenMark Diagnostics provides preliminary operational and financial results for 2019 297
6.34 Jan 12, 2020: Hologic announces preliminary financial results for first quarter of fiscal 2020 297
6.35 Jan 12, 2020: Invitae preliminary 2019 financial results demonstrate strong momentum with nearly 60% growth in test volume and more than 45% growth in revenue year-over-year 298
6.36 Jan 06, 2020: Interpace Biosciences announces collaborative study with University of North Carolina to assess the use BarreGEN after Ablation of dysplastic barrett’s esophagus 299
6.37 Jan 06, 2020: Natera announces achievement of $55 million in pharma contracts and issuance of new oncology patents 300
6.38 Jan 02, 2020: Agilent expands cross-vendor CDS instrument control 300
6.39 Dec 29, 2019: Illumina reports financial results for fourth quarter and fiscal year 2019 301
6.40 Dec 24, 2019: Ad-hoc announcement pursuant to article 17 market abuse regulation 303
6.41 Dec 19, 2019: PAVmed subsidiary Lucid Diagnostics announces commercial launch of EsoGuard Esophageal DNA Test 303
6.42 Dec 10, 2019: Fluidigm expands Maxpar antibody portfolio for high-multiplex tissue imaging 304
6.43 Dec 04, 2019: Myriad’s Prequel Prenatal Screen has superior sensitivity in women with high BMI undergoing non-invasive prenatal screening 304
6.44 Dec 03, 2019: genedrive: Antibiotic Induced Hearing Loss assay kit demonstrates high clinical accuracy 305
6.45 Dec 02, 2019: Yourgene Health: Half-year Report 306
6.46 Nov 28, 2019: Yourgene Health: Opening of new facilities and corporate HQ 307
6.47 Nov 26, 2019: MyHeritage adds 9 new reports to its Genetic Health product 307
6.48 Nov 26, 2019: LabCorp appoints senior finance executive Jeffrey A. Davis to its Board of Directors 309
7 Appendix 310
7.1 Methodology 310
7.2 About GlobalData 314
7.3 Contact Us 314
